[go: up one dir, main page]

DK1701942T3 - Inhibitorer for ikke-nukleotid revers transkriptase - Google Patents

Inhibitorer for ikke-nukleotid revers transkriptase

Info

Publication number
DK1701942T3
DK1701942T3 DK04809207.6T DK04809207T DK1701942T3 DK 1701942 T3 DK1701942 T3 DK 1701942T3 DK 04809207 T DK04809207 T DK 04809207T DK 1701942 T3 DK1701942 T3 DK 1701942T3
Authority
DK
Denmark
Prior art keywords
alkyl
orx
nrxrx
reverse transcriptase
transcriptase inhibitors
Prior art date
Application number
DK04809207.6T
Other languages
English (en)
Inventor
Christian Sund
Nathalie Roue
Stefan Lindstroem
Dmitry Antonov
Christer Sahlberg
Katarina Jansson
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400021A external-priority patent/SE0400021D0/xx
Priority claimed from SE0400585A external-priority patent/SE0400585D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of DK1701942T3 publication Critical patent/DK1701942T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK04809207.6T 2004-01-08 2004-12-30 Inhibitorer for ikke-nukleotid revers transkriptase DK1701942T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0400021A SE0400021D0 (sv) 2004-01-08 2004-01-08 Non-nucleoside reverse transcriptase inhibitors
SE0400585A SE0400585D0 (sv) 2004-03-09 2004-03-09 NNRTI Antivirals
PCT/SE2004/002034 WO2005066131A1 (en) 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
DK1701942T3 true DK1701942T3 (da) 2010-04-06

Family

ID=34752289

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04809207.6T DK1701942T3 (da) 2004-01-08 2004-12-30 Inhibitorer for ikke-nukleotid revers transkriptase

Country Status (15)

Country Link
US (1) US7915295B2 (da)
EP (1) EP1701942B1 (da)
JP (1) JP4762917B2 (da)
AT (1) ATE451357T1 (da)
AU (1) AU2004312284B2 (da)
BR (1) BRPI0418306B8 (da)
CA (1) CA2550187C (da)
DE (1) DE602004024584D1 (da)
DK (1) DK1701942T3 (da)
EA (1) EA009700B1 (da)
ES (1) ES2337794T3 (da)
IL (1) IL176740A (da)
NZ (1) NZ548367A (da)
SG (1) SG149070A1 (da)
WO (1) WO2005066131A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1694700A (zh) * 2002-09-05 2005-11-09 美迪维尔公司 非核苷逆转录酶抑制剂
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
EP1877091B1 (en) * 2005-04-27 2015-03-25 TaiMed Biologics, Inc. Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
WO2007062526A1 (en) 2005-11-30 2007-06-07 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
WO2007136572A2 (en) * 2006-05-15 2007-11-29 Merck & Co., Inc. Antidiabetic bicyclic compounds
CA2664118A1 (en) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Protease inhibitors
EP3250552B1 (en) * 2015-01-30 2019-03-27 Genentech, Inc. Therapeutic compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299387B6 (cs) * 1998-01-16 2008-07-09 Medivir Ab Antivirové slouceniny
WO1999051613A1 (en) 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) * 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
CN1694700A (zh) * 2002-09-05 2005-11-09 美迪维尔公司 非核苷逆转录酶抑制剂

Also Published As

Publication number Publication date
EA200601289A1 (ru) 2006-12-29
WO2005066131A1 (en) 2005-07-21
BRPI0418306A (pt) 2007-05-02
BRPI0418306B8 (pt) 2021-05-25
ATE451357T1 (de) 2009-12-15
DE602004024584D1 (de) 2010-01-21
JP4762917B2 (ja) 2011-08-31
AU2004312284A2 (en) 2005-07-21
EP1701942B1 (en) 2009-12-09
AU2004312284A1 (en) 2005-07-21
EA009700B1 (ru) 2008-02-28
NZ548367A (en) 2010-06-25
IL176740A (en) 2011-09-27
SG149070A1 (en) 2009-01-29
HK1101400A1 (en) 2007-10-18
US7915295B2 (en) 2011-03-29
BRPI0418306B1 (pt) 2018-09-18
US20080070951A1 (en) 2008-03-20
JP2007519640A (ja) 2007-07-19
AU2004312284B2 (en) 2010-08-05
ES2337794T3 (es) 2010-04-29
EP1701942A1 (en) 2006-09-20
IL176740A0 (en) 2006-10-31
CA2550187A1 (en) 2005-07-21
CA2550187C (en) 2012-08-07

Similar Documents

Publication Publication Date Title
PH12012501773A1 (en) Arylethynyl derivatives
EA200602060A1 (ru) Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
JP2013531029A5 (da)
EA201591000A1 (ru) Пирролобензодиазепины
NZ596615A (en) Substituted isoquinoline derivative
MX2014004144A (es) Derivados de etinilo como moduladores alostericos del receptor de glutamato metabotropico del subtipo 5 (mglur5).
NO20080738L (no) Fremgangsmater for neurobeskyttelse
TW200608972A (en) Aryl-pyridine derivatives
AR039698A1 (es) Agonistas de los receptores cannabinoides
ATE94061T1 (de) Arylsubstituierte aminderivate verwendbar in der krebstherapie.
JP2010527915A5 (da)
EA200970793A1 (ru) Модуляторы рецепторов, активируемых пролифераторами пероксисом
DK1701942T3 (da) Inhibitorer for ikke-nukleotid revers transkriptase
EA201101298A1 (ru) Аддитивные соли трометамина с производными азабифениламинобензойной кислоты в качестве ингибиторов dhodh
MX2012006789A (es) Derivados de etinilo.
MX2007005155A (es) Nuevos derivados de aminopiridina que tienen accion inhibidora selectiva de la aurora a.
WO2009007536A3 (fr) Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique
WO2008078445A1 (ja) 重合性化合物及び重合性組成物
CO5690608A2 (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica
IN2014DN02947A (da)
GB2470170A (en) Dithienothiophene derivatives
JP2012006843A5 (da)
MX2010008448A (es) Compuesto de bencilpiperizina.
CO5170535A1 (es) Derivados de n-[2-(4-aminofenil)etil]2,3-dihidro-1,4- benzodioxin-2-metanamina, su preparacion y su aplciacion en terapeutica
MX2010001512A (es) Nuevo procedimiento de preparacion.